0001225208-22-002583.txt : 20220217
0001225208-22-002583.hdr.sgml : 20220217
20220217164711
ACCESSION NUMBER: 0001225208-22-002583
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220215
FILED AS OF DATE: 20220217
DATE AS OF CHANGE: 20220217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: West Nadja
CENTRAL INDEX KEY: 0001787802
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 22648876
MAIL ADDRESS:
STREET 1: 1915 REXFORD ROAD
CITY: CHARLOTTE
STATE: NC
ZIP: 28211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0102
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2022-02-15
0000200406
JOHNSON & JOHNSON
JNJ
0001787802
West Nadja
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
Deferred Share Units
2022-02-15
4
A
0
1175.0000
0.0000
A
Common Stock
1175.0000
2326.8450
D
Grant of Deferred Share Units acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date).
Raavi K. Deol, as attorney-in-fact for Nadja Y. West
2022-02-17